RESMED INC — Director's Dealing 2026

Feb 10, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2026-02-09

Reporting Person: Farrell Michael J. (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-09	ResMed Common Stock	M	4991	$146.34	Acquired	471214	Direct
2026-02-09	ResMed Common Stock	S	4991	$273.7801	Disposed	466223	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-09	ResMed Common Stock Options	$146.34	M	4991	Disposed	2026-11-21	ResMed Common Stock (4991)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	2090	Indirect

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

F2: This transaction was executed in multiple trades at prices ranging from $270.25 - $276.35. The price reported above reflects the weighted average sale price.

F3: Represents date options first become exercisable. Options vest 1/3 per year.